GGrantIndex
← Search

COLLAGENASE IN THE TREATMENT OF DUPUYTREN'S DISEASE

$0M01FY2000RRNIH

State University New York Stony Brook, Stony Brook NY

Investigators

Linked publications & trials

Abstract

A Phase II random, placebo double blind trial of injectable collagenase is being studied as a non-operative treatment for Dupuytren's disease, a fixed flexion contracture deformity of the hand. This therapy may obviate the need for surgical fasciectomy for Dupuytren's disease.

View original record on NIH RePORTER →